Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Cyst Fibros. 2018 Aug 29;18(2):251–264. doi: 10.1016/j.jcf.2018.08.001

Table 2c.

Spearman correlation coefficients for EQ-5D-5L domains versus CFRSD-CRISS questions on the patients’ 3rd measurement at the end of PEx treatment.

AGE <18
CFRSD-CRISS
Breathing
CFRSD-CRISS
Feverish
CFRSD-CRISS
Tired
CFRSD-CRISS
Chills
CFRSD-CRISS
Cough
CFRSD-CRISS
Mucus Quantity
CFRSD-CRISS
Chest Tightness
CFRSD-CRISS
Wheezing
EQ-5D-5L
Mobility
0.16 0.33 0.06 0.24 0.08 0.01 0.12 −0.10
EQ-5D-5L
Self-Care
0.19 −0.06 −0.07 −0.08 −0.01 −0.21 −0.12 −0.08
EQ-5D-5L
Usual Activities
0.19 0.20 0.32 0.38 0.18 −0.14 0.20 0.13
EQ-5D-5L
Pain/ Discomfort
0.02 0.09 0.13 0.01 0.09 0.10 0.36 0
EQ-5D-5L Anxiety/ Depression 0.32 −0.14 0.52 0.06 0.52 0.18 0.33 0.14
AGE ≥18
CFRSD-CRISS
Breathing
CFRSD-CRISS
Feverish
CFRSD-CRISS
Tired
CFRSD-CRISS
Chills
CFRSD-CRISS
Cough
CFRSD-CRISS
Mucus Quantity
CFRSD-CRISS
Chest Tightness
CFRSD-CRISS
Wheezing
EQ-5D-5L
Mobility
0.43 0.15 0.21 0.24 0.19 0.19 0.32 0.03
EQ-5D-5L
Self-Care
0.23 −0.05 0.23 −0.10 0.11 0.12 0.08 −0.01
EQ-5D-5L
Usual Activities
0.44 0.11 0.40 0.17 0.13 0.26 0.23 0.15
EQ-5D-5L
Pain/ Discomfort
0.44 0.23 0.44 0.27 0.34 0.27 0.31 0.32
EQ-5D-5L Anxiety/ Depression 0.32 0.23 0.33 0.22 0.16 0.21 0.21 0.16